Aug 27 |
Weight-Loss Drugs Get More Good News. For Investors, It’s Still Too Soon to Celebrate.
|
Aug 26 |
Top Research Reports for Eli Lilly, Chevron & Abbott
|
Aug 26 |
Buy 4 Top-Ranked Stocks to Play Likely Earnings Beat
|
Aug 26 |
Here's Why You Should Consider Buying Akebia (AKBA) Stock
|
Aug 26 |
J&J (JNJ) Gets EU Approval for Bladder Cancer Drug Balversa
|
Aug 25 |
Why Viking Therapeutics could be 'onto something pretty amazing'
|
Aug 25 |
Eli Lilly, Novo Nordisk to maintain 'two horse race' in GLP-1 weight loss market
|
Aug 25 |
Mounjaro Scores Yet Another Win: Why Eli Lilly Is Still a Buy
|
Aug 24 |
If You Like Eli Lilly, Then You'll Love This Little-Known Specialty Manufacturing Stock
|
Aug 24 |
Eli Lilly Alzheimer’s drug set to face same fate as Biogen’s in U.K.: report
|